SUCLG2

succinate-CoA ligase GDP-forming subunit beta

Basic information

Region (hg38): 3:67360460-67654612

Links

ENSG00000172340NCBI:8801OMIM:603922HGNC:11450Uniprot:Q96I99AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SUCLG2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SUCLG2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
17
clinvar
1
clinvar
18
missense
63
clinvar
4
clinvar
6
clinvar
73
nonsense
2
clinvar
2
start loss
0
frameshift
4
clinvar
1
clinvar
5
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
splice region
1
4
2
7
non coding
16
clinvar
8
clinvar
24
Total 0 0 70 37 16

Variants in SUCLG2

This is a list of pathogenic ClinVar variants found in the SUCLG2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-67360640-A-G Uncertain significance (Jul 19, 2022)1938120
3-67360675-G-A Uncertain significance (Jan 10, 2024)2957150
3-67360676-C-T Uncertain significance (Jun 11, 2022)1916871
3-67360679-C-T not specified Benign (Feb 01, 2024)257600
3-67360689-G-T Likely benign (Jul 31, 2023)2748887
3-67360707-A-T SUCLG2-related disorder Uncertain significance (Jan 29, 2024)1394676
3-67360719-T-C Likely benign (Dec 12, 2023)2817749
3-67360738-A-G Uncertain significance (Nov 04, 2021)1496942
3-67360742-A-G not specified Benign (Feb 01, 2024)257599
3-67360748-CT-C Benign (Jan 22, 2024)791936
3-67375857-T-C SUCLG2-related disorder Benign (Jul 08, 2019)3056708
3-67375866-G-A SUCLG2-related disorder Benign (Sep 12, 2019)3056433
3-67375869-G-A SUCLG2-related disorder Likely benign (Oct 03, 2019)3045530
3-67400711-G-A Benign (Jan 22, 2024)1988819
3-67400739-C-T Uncertain significance (Jan 20, 2024)2753199
3-67400752-G-C not specified Uncertain significance (May 06, 2022)2363351
3-67400764-C-T not specified Uncertain significance (Apr 17, 2024)3323519
3-67400772-C-T Likely benign (Aug 04, 2023)2080642
3-67400773-G-A not specified Benign (Feb 01, 2024)257598
3-67400793-T-C Uncertain significance (Jan 15, 2022)1370835
3-67400794-T-G Uncertain significance (Jan 04, 2024)2981426
3-67400808-C-A not specified Uncertain significance (Aug 10, 2021)2212257
3-67400815-C-T not specified Uncertain significance (Mar 20, 2023)2526945
3-67400816-G-A Likely benign (Jul 13, 2022)766006
3-67400818-T-C not specified Uncertain significance (Feb 03, 2022)2276009

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SUCLG2protein_codingprotein_codingENST00000493112 11294155
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
5.72e-140.01531247151781247940.000317
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.4882442231.090.00001142860
Missense in Polyphen9484.9261.10691013
Synonymous0.1828284.10.9750.00000476850
Loss of Function-0.1292019.41.039.06e-7251

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001050.00105
Ashkenazi Jewish0.000.00
East Asian0.0003340.000334
Finnish0.0001860.000186
European (Non-Finnish)0.0001780.000168
Middle Eastern0.0003340.000334
South Asian0.0006430.000588
Other0.0001680.000165

dbNSFP

Source: dbNSFP

Function
FUNCTION: GTP-specific succinyl-CoA synthetase functions in the citric acid cycle (TCA), coupling the hydrolysis of succinyl-CoA to the synthesis of GTP and thus represents the only step of substrate-level phosphorylation in the TCA. The beta subunit provides nucleotide specificity of the enzyme and binds the substrate succinate, while the binding sites for coenzyme A and phosphate are found in the alpha subunit. {ECO:0000255|HAMAP- Rule:MF_03221}.;
Pathway
Citrate cycle (TCA cycle) - Homo sapiens (human);Propanoate metabolism - Homo sapiens (human);Valproic Acid Pathway, Pharmacodynamics;Pathway_PA165964473;Warburg Effect;The oncogenic action of Succinate;The oncogenic action of Fumarate;Pyruvate dehydrogenase deficiency (E3);Pyruvate dehydrogenase deficiency (E2);2-ketoglutarate dehydrogenase complex deficiency;Mitochondrial complex II deficiency;Fumarase deficiency;Congenital lactic acidosis;Citric Acid Cycle;Glutaminolysis and Cancer;The oncogenic action of 2-hydroxyglutarate;The oncogenic action of L-2-hydroxyglutarate in Hydroxygluaricaciduria;The oncogenic action of D-2-hydroxyglutarate in Hydroxygluaricaciduria ;miR-targeted genes in lymphocytes - TarBase;TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc);TCA Cycle;Citrate cycle;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;TCA cycle;TCA cycle;superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle (Consensus)

Recessive Scores

pRec
0.498

Intolerance Scores

loftool
0.900
rvis_EVS
0.62
rvis_percentile_EVS
83.36

Haploinsufficiency Scores

pHI
0.232
hipred
N
hipred_score
0.389
ghis
0.497

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.652

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Suclg2
Phenotype
homeostasis/metabolism phenotype; cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
tricarboxylic acid cycle;succinyl-CoA metabolic process;succinate metabolic process
Cellular component
mitochondrion;mitochondrial matrix;plasma membrane;succinate-CoA ligase complex (GDP-forming)
Molecular function
magnesium ion binding;succinate-CoA ligase (ADP-forming) activity;succinate-CoA ligase (GDP-forming) activity;protein binding;ATP binding;GTP binding;GDP binding;protein heterodimerization activity